NEWS What’s New in the CVF Portfolio? Feb 19, 2026Ten63 Therapeutics Closes Strategic Financing, Bringing Total Funding to More Than $45M to Scale the Next-Generation of Artificial Intelligent Drug DiscoveryJan 29, 2026 Repertoire® Immune Medicines Announces Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune DiseasesJan 16, 2026 JPM26: Chugai chases new science and name recognition from US biopharma industry 2026 Sep 16, 2025 Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory DiseaseMay 13, 2025Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy 2025 Nov 12, 2024Hyku Biosciences Appoints John Gustofson to its Board of Directors 2024 Jun 27, 2023Chugai Establishes Corporate Venture Capital to Accelerate Innovation Opportunities with Drug Discovery Start-ups 2023
